Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Taxol | 0.31623 | uM | 3 | 312.50 | 136.54 | 112.33 | 305.25 | 0.3766 | -0.1639 |
| BT-20 | Taxol | 1 | uM | 3 | 312.50 | 136.54 | 137.00 | 305.25 | 0.4673 | 0.0246 |
| BT-20 | Etoposide | 0.0033113 | uM | 3 | 312.50 | 136.54 | 368.00 | 294.17 | 1.2555 | 1.4657 |
| BT-20 | Etoposide | 0.01 | uM | 3 | 312.50 | 136.54 | 356.33 | 294.17 | 1.2107 | 1.3748 |
| BT-20 | Etoposide | 0.031623 | uM | 3 | 312.50 | 136.54 | 336.67 | 294.17 | 1.1451 | 1.2619 |
| BT-20 | Etoposide | 0.1 | uM | 3 | 312.50 | 136.54 | 404.67 | 294.17 | 1.3820 | 1.6918 |
| BT-20 | Etoposide | 0.31623 | uM | 3 | 312.50 | 136.54 | 328.00 | 294.17 | 1.1182 | 1.2195 |
| BT-20 | Etoposide | 1 | uM | 3 | 312.50 | 136.54 | 272.00 | 294.17 | 0.9226 | 0.8534 |
| BT-20 | Etoposide | 3.1623 | uM | 3 | 312.50 | 136.54 | 216.00 | 294.17 | 0.7338 | 0.5111 |
| BT-20 | Etoposide | 10 | uM | 3 | 312.50 | 136.54 | 174.00 | 294.17 | 0.5918 | 0.2448 |
| BT-20 | Etoposide | 19.9526 | uM | 3 | 312.50 | 136.54 | 156.33 | 294.17 | 0.5324 | 0.1316 |
| BT-20 | Nilotinib | 0.0033113 | uM | 3 | 312.50 | 136.54 | 391.33 | 294.17 | 1.3323 | 1.5976 |
| BT-20 | Nilotinib | 0.01 | uM | 3 | 312.50 | 136.54 | 349.67 | 294.17 | 1.1909 | 1.3468 |
| BT-20 | Nilotinib | 0.031623 | uM | 3 | 312.50 | 136.54 | 378.67 | 294.17 | 1.2897 | 1.5233 |
| BT-20 | Nilotinib | 0.1 | uM | 3 | 312.50 | 136.54 | 333.67 | 294.17 | 1.1396 | 1.2615 |
| BT-20 | Nilotinib | 0.31623 | uM | 3 | 312.50 | 136.54 | 369.67 | 294.17 | 1.2622 | 1.4790 |
| BT-20 | Nilotinib | 1 | uM | 3 | 312.50 | 136.54 | 406.00 | 294.17 | 1.3794 | 1.6728 |
| BT-20 | Nilotinib | 3.1623 | uM | 3 | 312.50 | 136.54 | 341.67 | 294.17 | 1.1614 | 1.2891 |
| BT-20 | Nilotinib | 10 | uM | 3 | 312.50 | 136.54 | 668.33 | 294.17 | 2.2694 | 3.1857 |
| BT-20 | Nilotinib | 19.9526 | uM | 3 | 312.50 | 136.54 | 1326.00 | 294.17 | 4.5083 | 6.8128 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 3 | 312.50 | 136.54 | 403.00 | 294.17 | 1.3696 | 1.6562 |
| BT-20 | PLX-4720 | 0.01 | uM | 3 | 312.50 | 136.54 | 361.67 | 294.17 | 1.2338 | 1.4274 |
| BT-20 | PLX-4720 | 0.031623 | uM | 3 | 312.50 | 136.54 | 322.67 | 294.17 | 1.0949 | 1.1647 |
| BT-20 | PLX-4720 | 0.1 | uM | 3 | 312.50 | 136.54 | 369.00 | 294.17 | 1.2563 | 1.4633 |
| BT-20 | PLX-4720 | 0.31623 | uM | 3 | 312.50 | 136.54 | 321.33 | 294.17 | 1.0949 | 1.1746 |